242 related articles for article (PubMed ID: 8899209)
1. Unexplained effusions: association with allogeneic bone marrow transplantation and acute or chronic graft-versus-host disease.
Pretnar J; Cernelc P; Mlakar U; Fortuna M
Bone Marrow Transplant; 1996 Oct; 18(4):826. PubMed ID: 8899209
[No Abstract] [Full Text] [Related]
2. Unexplained effusions: association with allogeneic bone marrow transplantation and acute or chronic graft-versus-host disease.
Seber A; Khan SP; Kersey JH
Bone Marrow Transplant; 1996 Feb; 17(2):207-11. PubMed ID: 8640168
[TBL] [Abstract][Full Text] [Related]
3. Massive pericardial and pleural effusion with anasarca following allogeneic bone marrow transplantation.
Ueda T; Manabe A; Kikuchi A; Yoshino H; Ebihara Y; Ishii T; Yagasaki H; Mitsui T; Hisakawa H; Masunaga A; Tsuji K; Nakahata T
Int J Hematol; 2000 Jun; 71(4):394-7. PubMed ID: 10905062
[TBL] [Abstract][Full Text] [Related]
4. Massive pericardial effusion complicating the course of chronic graft-versus-host disease (cGVHD) in a child with acute lymphoblastic leukemia following allogeneic bone marrow transplantation.
Toren A; Nagler A
Bone Marrow Transplant; 1997 Nov; 20(9):805-7. PubMed ID: 9384488
[TBL] [Abstract][Full Text] [Related]
5. [Allogeneic skin transplantation in chronic graft-versus-host disease following bone marrow transplantation].
Baumeister RG; Riel KA; Kolb HJ
Chirurg; 1990 Jun; 61(6):438-40. PubMed ID: 2364784
[TBL] [Abstract][Full Text] [Related]
6. Coronary artery disease following bone marrow transplantation.
Chan KW; Taylor GP; Shepherd JD; Shepherd WE
Bone Marrow Transplant; 1989 May; 4(3):327-30. PubMed ID: 2659118
[TBL] [Abstract][Full Text] [Related]
7. A case of cardiac localization of graft-versus-host disease after allogenic bone marrow transplantation.
Cereda M; Trocino G; Pogliani EM; Schiavina R
Ital Heart J; 2003 Jan; 4(1):60-3. PubMed ID: 12690924
[TBL] [Abstract][Full Text] [Related]
8. Impact of cyclosporine and methylprednisolone dose used for prophylaxis and therapy of graft-versus-host disease on survival and relapse after allogeneic bone marrow transplantation.
Michallet M; Perrin MC; Belhabri A; Molina L; Nicolini F; Tigaud JD; Sotto JJ; Guyotat D; Fière D; Archimbaud E
Bone Marrow Transplant; 1999 Jan; 23(2):145-50. PubMed ID: 10197799
[TBL] [Abstract][Full Text] [Related]
9. Busulfan, cyclophosphamide and total body irradiation as conditioning for allogeneic bone marrow transplantation for acute and chronic myeloid leukemia.
Hirabayashi N; Goto S; Ishii M; Yuge M; Mitsuma A; Noda N
Bone Marrow Transplant; 1998 Jun; 21(11):1079-83. PubMed ID: 9645568
[TBL] [Abstract][Full Text] [Related]
10. Myasthenia gravis after allogeneic bone marrow transplantation: report of a new case and pathogenetic considerations.
Grau JM; Casademont J; Monforte R; Marín P; Grañena A; Rozman C; Urbano-Márquez A
Bone Marrow Transplant; 1990 Jun; 5(6):435-7. PubMed ID: 2369684
[TBL] [Abstract][Full Text] [Related]
11. Esophageal graft versus host disease.
Sodhi SS; Srinivasan R; Thomas RM
Gastrointest Endosc; 2000 Aug; 52(2):235. PubMed ID: 10922099
[No Abstract] [Full Text] [Related]
12. Epidermolysis bullosa acquisita, a rare late complication of allogeneic bone marrow transplantation?
Burger J; Gmür J; Bruckner-Tuderman L
Bone Marrow Transplant; 1992 Feb; 9(2):139-41. PubMed ID: 1571712
[TBL] [Abstract][Full Text] [Related]
13. Influence of ultraviolet-B irradiation on engraftment, graft-versus-host disease and graft-versus-leukemia effect in a rat model for allogeneic bone marrow transplantation.
Gowing H; Braakman E; Hagenbeek A; Lawler M; McCann SR; Pamphilon DH; Martens AC
Bone Marrow Transplant; 1998 Apr; 21(8):801-7. PubMed ID: 9603404
[TBL] [Abstract][Full Text] [Related]
14. Allogeneic BMT for acute leukemia [proceedings].
Cornu P; Speck B; Groff P; Nissen C; Sartorius J; Burri HP; Ohnacker H
Pathol Biol (Paris); 1978 Jan; 26(1):49-50. PubMed ID: 358089
[No Abstract] [Full Text] [Related]
15. Polyvisceral arteritis in chronic graft-versus-host disease: antiphospholipid-negative thrombotic syndrome mimicking polyarteritis nodosa.
Ysebaert L; Deconinck E; Larosa F; Caillot D; Tiberghien P; Casasnovas RO; Cahn JY
Bone Marrow Transplant; 2002 May; 29(10):873-4. PubMed ID: 12058239
[TBL] [Abstract][Full Text] [Related]
16. High dose chemotherapy with busulfan, cyclophosphamide, and etoposide as conditioning regimen for allogeneic bone marrow transplantation for patients with acute myeloid leukemia in first complete remission.
Zander AR; Berger C; Kröger N; Stockshläder M; Krüger W; Horstmann M; Grimm J; Zeller W; Kabisch H; Erttmann R; Schönrock P; Kuse R; Braumann D; Illiger HJ; Fiedler W; de Witt M; Hossfeld KD; Weh HJ
Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2671-5. PubMed ID: 10068272
[TBL] [Abstract][Full Text] [Related]
17. Eosinophilia after allogeneic bone marrow transplantation using busulfan and cyclophosphamide conditioning regimen.
Arslan O; Akan H; Koç H; Beksaç M; Ilhan O; Ozcan M; Yalçín S; Gürman G; Konuk N; Uysal A
Bone Marrow Transplant; 1996 Jul; 18(1):261. PubMed ID: 8832034
[No Abstract] [Full Text] [Related]
18. Prevention of graft versus host disease following allogeneic bone marrow transplantation.
Powles RL; Goss GD; Millar J; Maitland J; Borthwick-Clark C; Al-Jundi A
Tokai J Exp Clin Med; 1985 Jun; 10(2-3):133-8. PubMed ID: 3914738
[No Abstract] [Full Text] [Related]
19. [Allogeneic bone marrow transplantation and myeloid leukemia in the chronic and accelerated stages].
Gyger M; Perreault C; Bélanger R; Bonny Y; David M; Boileau J; Lavallée R; Lacombe M; D'Angelo G; Tawil E
Union Med Can; 1988; 117(2):169, 173-4, 177-8. PubMed ID: 3041661
[No Abstract] [Full Text] [Related]
20. Allogeneic bone marrow transplantation for childhood leukemia following a busulfan and melphalan preparative regimen.
Matsuyama T; Kojima S; Kato K
Bone Marrow Transplant; 1998 Jul; 22(1):21-6. PubMed ID: 9678791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
